London, UK (PRWEB) January 15, 2014
Currently, the diabetes testing represents the biggest market for the endocrine function diagnostics. The world prevalence of diabetes is anticipated to increase from nearly 382 million in 2013 to around 592 million in 2035, spurring considerably the global endocrine function diagnostics market. The main market growth stimulators include, among others, the high prevalence of some other diseases (hypothyroidism, polycystic ovary syndrome and hyperthyroidism, etc.), technological advancements in the endocrine function diagnostics, increasing healthcare IT penetration, steadily improving reimbursement and regulatory frameworks worldwide. North America is the dominant regional market for endocrine function diagnostics. BioMerieux, Beckman Coulter/Danaher, Instrumentation Laboratory, Roche, Kyowa Medex, Fujirebio, Abbott Laboratories, Thermo Fisher and Bio-Rad are among the entrenched players in the world endocrine function diagnostics market.
The endocrine function diagnostics market is poised to undergo considerable changes during the next decade. The market development is expected to be influenced by novel more stringent regulations, intensifying competition and further advances in diagnostic technologies, automation, IT and system engineering. The rapidly-evolving market will likely open a broad range of opportunities for a slew of new auxiliary products, reagent systems, instruments, etc. The APAC market is predicted to register the highest growth pace in the offing, driven by the high unmet medical needs in the region.
New research report “World Endocrine Function Diagnostics Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles of Key Players” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.
Title: World Endocrine Function Diagnostics Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles of Key Players
Published: January, 2014
Price: US$ 8,500.00
Cutting-edge information on the performance of the worldwide market for endocrine function diagnostics in tandem with a comprehensive market assessment is provided in the in-demand research study. The report delves deeply into the current market scenario, presents an all-round summary of the existing tests and technologies, uncovers sales statistics, and also grants access to all-encompassing country market analyses. The study offers extensive examination of the competitive landscape, discusses the main market-entry barriers and risks in detail, reviews the leading players in the world marketplace, identifies the top market-penetration strategies, and outlines and evaluates the major emerging market opportunities. In addition, the report contains an insightful future outlook for the global endocrine function diagnostics market including test volume and sales projections.
- Insightful overview of the worldwide market for endocrine function diagnostics market.
- Extensive snapshot of the existing technologies and tests.
- Comprehensive country-wide markets analyses for the US, the UK, Spain, Japan, Italy, France and Germany.
- Valuable information on the design criteria for decentralized testing products.
- Thorough discussions alternative market-penetration strategies.
- Review of the potential market-entry barriers and risks.
- Competitive outlook.
- Detailed profiles of the dominant market participants.
- Future outlook for the global endocrine function diagnostics market including test volume and sales projections by market segment and assay.
More new research reports by the publisher can be found at VPG page.